Issue 24, 2012
From the journal:

CrystEngComm

Polymorphism of the β,γ-hydroxylactone derived from indomethacin†

Nikoletta B. Báthori*a  and  Clive L. Oliver*b  

* Corresponding authors

a Crystal Engineering Research Unit, Department of Chemistry, Cape Peninsula University of Technology, P.O. Box 652, Cape Town, South Africa
E-mail: bathorin@cput.ac.za
Fax: +27 21 460 3854
Tel: +27 21 460 8354

b Centre for Supramolecular Chemistry Research, Department of Chemistry, University of Cape Town, South Africa
E-mail: clive.oliver@uct.ac.za
Fax: +27 21-650 5419
Tel: +27 21-650 3830

Abstract

Polymorphic crystal structures of an oxidative degradation product of indomethacin, a nonsteroidal anti-inflammatory drug were determined and analyzed.

Graphical abstract: Polymorphism of the β,γ-hydroxylactone derived from indomethacin

About
Cited by
Related
Download options Please wait...

Supplementary files

Article information

DOI
https://doi.org/10.1039/C2CE26188J
Article type
Communication
Submitted
23 Jul 2012
Accepted
26 Sep 2012
First published
15 Oct 2012

CrystEngComm, 2012,14, 8361-8364

Permissions

Request permissions

Polymorphism of the β,γ-hydroxylactone derived from indomethacin

N. B. Báthori and C. L. Oliver, CrystEngComm, 2012, 14, 8361 DOI: 10.1039/C2CE26188J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements